Brief: Moberg Pharma Q4 EBIT Loss Narrows To SEK 4.9 Million

Moberg Pharma AB (publ)

08/02/2022 07:11

Feb 8 (Reuters) - Moberg Pharma AB (publ)  MBPH.ST :
    * Q4 EBITDA SEK -4.2 MILLION (-5.3)
    * Q4 OPERATING PROFIT (EBIT) SEK -4.9 MILLION (-6.0)
    * Q4 PROFIT AFTER TAX SEK -4.0 MILLION (-5.7)

Source text for Eikon:  ID:nWkr9CcJxN 
Further company coverage:  MBPH.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))